ストックスクリーナーアプリを入手
2.95
3.28%
-0.10
アフターアワーズ：
2.96
0.010
+0.34%
前日終値:
$3.05
開ける：
$2.98
24時間の取引高:
313.81K
Relative Volume:
0.42
時価総額：
$1.48M
収益：
$29.78M
当期純損益:
$-39.94M
株価収益率:
-0.0476
EPS:
-61.9139
ネットキャッシュフロー:
$-16.12M
1週間 パフォーマンス:
-39.80%
1か月 パフォーマンス:
-59.31%
6か月 パフォーマンス:
-41.12%
1年 パフォーマンス:
-96.97%
1日の値動き範囲:
$2.93
$3.1993
1週間の範囲:
$2.88
$4.53
52週間の値動き範囲:
$0.432
$105.68
22nd Century Group, Inc. Stock (XXII) Company Profile
名前
22nd Century Group, Inc.
セクター
電話
716-270-1523
住所
8560 Main Street, Williamsville, NY
XXII を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
2.95 | 1.05M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-21 | 開始されました | Alliance Global Partners | Buy |
| 2022-06-15 | 開始されました | Craig Hallum | Buy |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2021-07-23 | 開始されました | Cowen | Outperform |
| 2017-10-16 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-08-11 | 繰り返されました | Chardan Capital Markets | Buy |
すべてを表示
22nd Century Group, Inc. (XXII) 最新ニュース
Should I buy 22nd Century Group Inc. stock before earningsUnprecedented profits - jammulinksnews.com
What drives 22nd Century Group Inc. stock priceExceptional gains - Autocar Professional
What analysts say about 22nd Century Group Inc. stockExplosive wealth accumulation - jammulinksnews.com
Is 22nd Century Group Inc. a good long term investmentFree Stock Selection - jammulinksnews.com
22nd Century Group Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
22nd Century Group Expands VLN Cigarette Sales Across U.S. - Tobacco Reporter
Why Did 22nd Century Group Drop 10.18% Despite FDA Approval? - AInvest
22nd Century Group hopes new reduced nicotine cigarette resonates with smokers - Greensboro News and Record
22nd Century Surges to 480th in Trading Volume with 1932% Spike Amid Major Acquisition - AInvest
XXII Secures Broader State Approvals for Product Sales Expansion - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Se - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products - The Globe and Mail
22nd Century Group’s Nicotine-Reduction Progress Accelerates Market Growth - StocksToTrade
22nd Century Group shares surge 56.11% intraday after expanding VLN® low-nicotine cigarette partnerships and meeting FDA's proposed nicotine limit. - AInvest
22nd Century Group Stock Soars as FDA’s Nicotine Crackdown Sparks Opportunity - RagingBull
22nd Century Stocks: Growth or Bubble? - timothysykes.com
Why Is 22nd Century Stock (XXII) Up 85% Today? - TipRanks
22nd Century Group (XXII) Stock Soars 110.04% on FDA Compliance - AInvest
22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push - Benzinga
22nd Century Group stock soars after expanding VLN cigarette partnerships - Investing.com
Tobacco brands partner with 22nd Century to expand reduced nicotine cigarettes By Investing.com - Investing.com South Africa
Tobacco brands partner with 22nd Century to expand reduced nicotine cigarettes - Investing.com Nigeria
22nd Century Group stock soars after expanding VLN cigarette partnerships By Investing.com - Investing.com Nigeria
VLN Commercial Launches Confirm Viability of the FDA’s Proposed Reduced Nicotine Mandate - The Manila Times
22nd Century Group Partners with Tobacco Brands to Promote VLN Reduced Nicotine Cigarettes in Compliance with FDA Standards - Quiver Quantitative
Exclusive: Major Tobacco Brands Adopt 95% Reduced-Nicotine Cigarettes Ahead of FDA Mandate - Stock Titan
What makes 22nd Century Group Inc. stock price move sharplySwing Trade Signals - beatles.ru
22nd Century Group stockholders approve share increase and reverse split measures - Investing.com India
22nd Century Approves Key Proposals at Annual Meeting - TipRanks
22nd Century Advances FDA Renewal for VLN - Tobacco Reporter
Top Premarket Decliners - MarketScreener
22nd Century Group Inc. shares fall 5.09% premarket after being listed as a top premarket decliner. - AInvest
The Nicotine Reset: 22nd Century Group's Path to Dominance in a Post-Addiction World - AInvest
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal ProcessThe First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less - The Manila Times
Breakthrough FDA-Authorized Cigarette Cuts Nicotine by 95%, Helps Smokers Quit - Stock Titan
Top 3 Risk Off Stocks That May Rocket Higher In Q3S&W Seed (NASDAQ:SANW), Shineco (NASDAQ:SISI) - Benzinga
22nd Century Targets Q4 to Have 100mm VLN to FDA - Tobacco Reporter
22nd Century Group developing 100mm very low nicotine cigarette - MSN
22nd Century Group to develop 100mm reduced nicotine cigarettes By Investing.com - Investing.com Canada
XXII Unveils New 100mm VLN Reduced Nicotine Cigarette Initiative | XXII Stock News - GuruFocus
22nd Century Group to develop 100mm reduced nicotine cigarettes - Investing.com
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain - Morningstar
22nd Century Announces Major Pinnacle Brand Expansion - Tobacco Reporter
22nd Century Group, Inc. (XXII) 財務データ
収益
当期純利益
現金流量
EPS
3.32%
1.57%
大文字化:
|
ボリューム (24 時間):